text: On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of << arylhydroxylamine >> carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and [[ cytochrome b5 ]] (cyt b5).